NCT06319729View on ClinicalTrials.gov

A Chinese Herbal Medicine for IBS-C

PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

78

Participants

Timeline

Start Date

March 25, 2024

Primary Completion Date

August 31, 2024

Study Completion Date

November 30, 2024

Conditions

Constipation-predominant Irritable Bowel Syndrome

Interventions

DRUG

CDD-2105

A Chinese herbal medicine formula containing four granular herbs.

DRUG

Placebo

Placebo

All Listed Sponsors

lead

Hong Kong Baptist University

OTHER